{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:46:28Z","timestamp":1794228388690,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP223fa627004"],"award-info":[{"award-number":["JP223fa627004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-034281"],"award-info":[{"award-number":["INV-034281"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eclinm.2024.102524","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T19:29:52Z","timestamp":1710185392000},"page":"102524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010\u201322: a modelling study"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-1576","authenticated-orcid":false,"given":"Kaja","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-913X","authenticated-orcid":false,"given":"Katelyn Jison","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiesha","family":"Prem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-8255","authenticated-orcid":false,"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102524_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eclinm.2024.102524_bib2","series-title":"Cervical cancer elimination initiative","author":"WHO","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102524_bib3","series-title":"Human papillomavirus vaccines (HPV), Immunization","author":"WHO","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102524_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eclinm.2024.102524_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agents Cancer"},{"key":"10.1016\/j.eclinm.2024.102524_bib6","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1016\/j.vaccine.2009.05.019","article-title":"WHO position on HPV vaccines","volume":"27","author":"World Health Organization","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2024.102524_bib7","first-page":"118","article-title":"Human papillomavirus vaccines. WHO position paper","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eclinm.2024.102524_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/21645515.2015.1065363","article-title":"Sustained immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: five-year clinical data and modeling predictions from a randomized study","volume":"12","author":"Romanowski","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eclinm.2024.102524_bib9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.102524_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.vaccine.2013.11.059","article-title":"Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16\/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months","volume":"32","author":"Lazcano-Ponce","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2024.102524_bib11","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1016\/j.vaccine.2014.12.002","article-title":"Human papillomavirus vaccines: WHO position paper, October 2014-Recommendations","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2024.102524_bib12","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations","volume":"35","author":"WHO","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2024.102524_bib13","series-title":"One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer","author":"WHO","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102524_bib14","series-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"WHO","year":"2020"},{"key":"10.1016\/j.eclinm.2024.102524_bib15","series-title":"UNICEF. Immunization data","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102524_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.eclinm.2024.102524_bib17","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-effectiveness of\u00a0female human papillomavirus vaccination in 179 countries: a\u00a0PRIME modelling study","volume":"2","author":"Jit","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2024.102524_bib18","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1016\/S2214-109X(20)30022-X","article-title":"Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study","volume":"8","author":"Abbas","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.eclinm.2024.102524_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003006","article-title":"Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries","volume":"5","author":"Ochalek","year":"2020","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.eclinm.2024.102524_bib20","series-title":"WHO. Report on the immunization and vaccines related implementation research (IVIR): Advisory Committee Meeting, Geneva, 17-19 September 2014","year":"2015"},{"key":"10.1016\/j.eclinm.2024.102524_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67635","article-title":"Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world","volume":"10","author":"Toor","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.eclinm.2024.102524_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(20)32657-X","article-title":"Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study","volume":"397","author":"Li","year":"2021","journal-title":"Lancet"},{"issue":"Suppl 5","key":"10.1016\/j.eclinm.2024.102524_bib23","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A\u00a0review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2024.102524_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0277-9536(91)90212-U","article-title":"On the measurement of inequalities in health","volume":"33","author":"Wagstaff","year":"1991","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.eclinm.2024.102524_bib25","series-title":"Analyzing health equity using household survey data: a guide to techniques and their implementation","author":"O'Donnell","year":"2007"},{"key":"10.1016\/j.eclinm.2024.102524_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12939-022-01678-5","article-title":"Vaccine equity in low and middle income countries: a systematic review and meta-analysis","volume":"21","author":"Ali","year":"2022","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.eclinm.2024.102524_bib27","series-title":"HPV vaccine included in national immunization programme","author":"WHO","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102524_bib28","series-title":"Guidance on an adapted evidence to recommendation process for national immunization technical advisory groups","author":"WHO","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102524_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1470-2045(22)00002-X","article-title":"Japan resumes active recommendations of HPV vaccine after 8\u00b75 years of suspension","volume":"23","author":"Haruyama","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eclinm.2024.102524_bib30","series-title":"HPV vaccination programme moves to single dose from September 2023","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102524_bib31","series-title":"Minister for health and aged care. Change to single dose HPV vaccine","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102524_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jnci\/djac189","article-title":"Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule","volume":"115","author":"Kreimer","year":"2023","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:02:23Z","timestamp":1778904143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"alternative-id":["S2589537024001032"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102524","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010\u201322: a modelling study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102524"}}